No abstract available
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / pharmacokinetics
-
Angiogenesis Inhibitors / therapeutic use*
-
Animals
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / pharmacokinetics
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Aptamers, Nucleotide / administration & dosage
-
Aptamers, Nucleotide / pharmacokinetics
-
Aptamers, Nucleotide / therapeutic use*
-
Bevacizumab
-
Diabetic Retinopathy / complications
-
Diabetic Retinopathy / drug therapy*
-
Diabetic Retinopathy / pathology
-
Disease Models, Animal
-
Humans
-
Injections
-
Macular Edema / drug therapy*
-
Macular Edema / etiology
-
Macular Edema / metabolism
-
Ranibizumab
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
-
Vascular Endothelial Growth Factor A / metabolism
-
Vitreous Body
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Aptamers, Nucleotide
-
Vascular Endothelial Growth Factor A
-
pegaptanib
-
Bevacizumab
-
Ranibizumab